SynAct Pharma AB (FRA:8F8)
1.814
+0.012 (0.67%)
At close: Dec 4, 2025
72.93% (1Y)
| Market Cap | 99.40M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -9.61M |
| Shares Out | n/a |
| EPS (ttm) | -0.20 |
| PE Ratio | n/a |
| Forward PE | 75.99 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | n/a |
| Open | 1.770 |
| Previous Close | 1.802 |
| Day's Range | 1.770 - 1.820 |
| 52-Week Range | 0.743 - 2.320 |
| Beta | n/a |
| RSI | 43.73 |
| Earnings Date | Feb 18, 2026 |